Evaluation of Serum Neurofilament Light Chain and Nerve Ultrasound in Diabetic Neuropathy
- PMID: 38124499
- DOI: 10.1002/jum.16393
Evaluation of Serum Neurofilament Light Chain and Nerve Ultrasound in Diabetic Neuropathy
Abstract
Objective: To assess the role of serum neurofilament light chain (NfL) levels in individuals with diabetic polyneuropathy (DPN) compared with controls, as well as to highlight the different sonographic changes in DPN and determine if NfL correlates with sonographic, clinical, and functional parameters.
Methods: Diabetic individuals with signs or symptoms consistent with peripheral nerve involvement were recruited. They were evaluated by examination, functional neuropathy severity scores, laboratory assessments (including NfL), nerve conduction studies (NCS), and ultrasound. Ultrasound was performed of the bilateral median, ulnar, tibial, fibular, sural, and vagus nerves, and cervical roots 5 and 6. Results were compared with age, sex, and body mass index matched healthy controls.
Results: A total of 320 nerves from 20 patients and 480 nerves from 30 controls were evaluated. NfL was significantly elevated in those with diabetes with a mean and standard deviation of 6.95 ± 2.95 pg/mL in the diabetic group and 2.83 ± 0.77 pg/mL in controls (P < .001). Nerve cross-sectional area and serum NfL levels correlated significantly with clinical and functional parameters and with each other (P < .05).
Conclusion: Individuals with DPN have significantly higher NfL levels than healthy controls, and NfL levels correlate with ultrasonographic parameters. These findings may be useful for the diagnosis, prognosis, and disease monitoring of those with DPN, though further exploration is needed.
Keywords: diabetic polyneuropathy; high-resolution ultrasonography; nerve area; neurofilament light chains.
© 2023 American Institute of Ultrasound in Medicine.
References
-
- Tesfaye S, Selvarajah D. Advances in epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 2012; 28:8-14.
-
- Said G. Diabetic neuropathy-a review. Nat Clin Pract Neurol 2007; 3:331-340.
-
- Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33:2285-2293.
-
- Morgenstern J, Groener JB, Jende JME, et al. Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia 2021; 64:2843-2855.
-
- Kocic G, Pavlovic V, Saranac LJ, et al. Circulating nucleic acids in type 1 diabetes may modulate the thymocyte turnover rate. Cell Immunol 2010; 266:76-82.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical